Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors

N Krishnamurthy, R Kurzrock - Cancer treatment reviews, 2018 - Elsevier
The Wnt/beta-catenin pathway is a family of proteins that is implicated in many vital cellular
functions such as stem cell regeneration and organogenesis. Several intra-cellular signal …

Tackling the cancer stem cells—what challenges do they pose?

DR Pattabiraman, RA Weinberg - Nature reviews Drug discovery, 2014 - nature.com
Since their identification in 1994, cancer stem cells (CSCs) have been objects of intensive
study. Their properties and mechanisms of formation have become a major focus of current …

Therapeutic modulation of Notch signalling—are we there yet?

ER Andersson, U Lendahl - Nature reviews Drug discovery, 2014 - nature.com
The Notch signalling pathway is evolutionarily conserved and is crucial for the development
and homeostasis of most tissues. Deregulated Notch signalling leads to various diseases …

[HTML][HTML] Notch signaling: an emerging therapeutic target for cancer treatment

X Yuan, H Wu, H Xu, H Xiong, Q Chu, S Yu, GS Wu… - Cancer letters, 2015 - Elsevier
The Notch pathway is involved in cell proliferation, differentiation and survival. The Notch
signaling pathway is one of the most commonly activated signaling pathways in cancer …

The Notch signaling pathway as a mediator of tumor survival

KM Capaccione, SR Pine - Carcinogenesis, 2013 - academic.oup.com
The Notch signaling pathway is evolutionarily conserved and responsible for cell fate
determination in the developing embryo and mature tissue. At the molecular level, ligand …

Targeting the notch signaling pathway in chronic inflammatory diseases

PF Christopoulos, TT Gjølberg, S Krüger… - Frontiers in …, 2021 - frontiersin.org
The Notch signaling pathway regulates developmental cell-fate decisions and has recently
also been linked to inflammatory diseases. Although therapies targeting Notch signaling in …

[HTML][HTML] Small cell lung cancer: can recent advances in biology and molecular biology be translated into improved outcomes?

PA Bunn Jr, JD Minna, A Augustyn, AF Gazdar… - Journal of Thoracic …, 2016 - Elsevier
Small cell lung cancer (SCLC) is one of the four major histological types of lung cancer. The
incidence of SCLC in developed countries has declined in recent years, presumably …

Crosstalk between Notch, HIF-1α and GPER in breast cancer EMT

EM De Francesco, M Maggiolini, AM Musti - International journal of …, 2018 - mdpi.com
The Notch signaling pathway acts in both physiological and pathological conditions,
including embryonic development and tumorigenesis. In cancer progression, diverse …

γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct

Y Ran, F Hossain, A Pannuti, CB Lessard… - EMBO molecular …, 2017 - embopress.org
Abstract γ‐Secretase inhibitors (GSI s) are being actively repurposed as cancer therapeutics
based on the premise that inhibition of NOTCH 1 signaling in select cancers is therapeutic …

Therapeutic targeting of notch signaling: from cancer to inflammatory disorders

F Allen, I Maillard - Frontiers in Cell and Developmental Biology, 2021 - frontiersin.org
Over the past two decades, the Notch signaling pathway has been investigated as a
therapeutic target for the treatment of cancers, and more recently in the context of immune …